Home
Alexza Pharmaceuticals

Alexza Pharmaceuticals Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainalexza.com

Year Founded2000

Employees51 - 200

Annual Revenue$5M - $10M

Alexza Pharmaceuticals

Alexza Pharmaceuticals (including company regionals)

alexza.com

See more website traffic and engagement information

Alexza Pharmaceuticals Revenue up to June 2026 is 5M - 10M

revenue generated by Alexza Pharmaceuticals top domains

Alexza Pharmaceuticals top domains revenue over 3 years

Revenue for Alexza Pharmaceuticals top domains

alexza.com5M - 10M

See more with Sales Intelligence

Total visits to Alexza Pharmaceuticals's top domains

Understand Alexza Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alexza.com2.4K

See more with Sales Intelligence

Avg. visit duration in Alexza Pharmaceuticals's top domains

Analyze Alexza Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alexza.com00:00:35

See more with Sales Intelligence

Avg. pageviews on Alexza Pharmaceuticals's top domains

See how Alexza Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alexza.com1.84

See more with Sales Intelligence

Alexza Pharmaceuticals top competitors by domain

Top similar sites in June 2026, ranked by their affinity

afnm.comCompany NameAffinium Pharmaceuticals, Inc.Employees51 - 200HQUnited States, Texas, AustinAnnual revenue$10M - $15MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Alexza Pharmaceuticals

These are the website technologies, by industry, used by Alexza Pharmaceuticals top domains

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

Mobile (3)

Meta Viewport

Widget (3)

Google Maps

More Technologies

6

See all

News & Signals from Alexza Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsUcb Group partnered with Alexza Pharmaceuticals, Inc. on Jun 1st '20.UCB acquired Engaged Therapeutics, Inc. for Staccato(R) alprazolam in June 2020 and entered into an updated license and related commercial supply agreement with Alexza.

NewsAlexza Pharmaceuticals, Inc. received award EU Certificate of GMP Compliance on Oct 2nd '18.Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA) announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer.